Caregiver Wellness After Traumatic Brain Injury (CG-WELL): An Intervention

Status Recruiting

Clinical Trial Summary

After injury, survivors of msTBI depend on informal family caregivers. Upwards of 77% of family caregivers experience poor outcomes, such as adverse life changes, poor health related quality of life, and increased depressive symptoms. Caregivers frequently report minimal support or training to prepare them for their new role. Periods of care transitions, such as ICU discharge, are most difficult. The majority (93%) of previously developed caregiver and caregiver/survivor dyad interventions after msTBI focus on providing information or practical skills to either survivors, or to long-term caregivers (>6 months post injury), rather than education, support, and skill-building that the new caregiver may use proactively that will benefit the dyad acutely after injury. The Aims of this proposal are to: (1) Determine feasibility, satisfaction, and data trends of CG-Well; and (2) Understand how baseline psychosocial risk factors affect response to CG-Well compared to an Information, Support, and Referral control group. To accomplish this, I will first enroll 6-10 caregivers and tailor CG-well until each finds the intervention acceptable, appropriate, and feasible. I will then enroll 100 (50/group) dyads and determine satisfaction ratings, recruitment, retention, and treatment fidelity of CG-Well. Additionally, I will determine if caregivers report reductions in depressive symptoms and improvements in life changes as a result of improvements in task difficulty and threat appraisal in CG-Well compared to ISR at six months. Information obtained in Aims 1 and 2 will be used to plan a larger Phase III trial of CG-Well. Completing these Aims and the training plan will improve outcomes of caregivers and downstream outcomes of survivors of msTBI, and provide me with the skillset necessary to become an independent researcher who can develop and test high-impact, high-fidelity, sustainable interventions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05307640
Study type	Interventional
Source	University of Cincinnati
Contact	Emily Werff
Phone	513-307-2963
Email	werffel@ucmail.uc.edu
Status	Recruiting
Phase	N/A
Start date	August 16, 2021
Completion date	April 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04527289` - Impact of Amantadine on Traumatic Brain Injury	Phase 4
Completed	`NCT04624152` - The Role of Hypoxia on Subconcussive Head Impacts	N/A
Active, not recruiting	`NCT04176640` - Quantifying Brain Injury on Computed Tomography in Hospitalized Children
Completed	`NCT05195996` - Beta Blocker Effects in Traumatic Brain Injury	Phase 4
Completed	`NCT03648476` - Intervention to Change Attributions That Are Negative (ICAN)	N/A
Not yet recruiting	`NCT05129514` - Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery	N/A
Completed	`NCT04397952` - Endotracheal Tube Cuff Pressure Measurement
Not yet recruiting	`NCT06057155` - Intracranial Pressure and Optic Nerve Sheath Diameter With CLOSED Bundle
Not yet recruiting	`NCT05818371` - Non-invasive ONSD-based Neuromonitoring in a Neurointensive Care Setting	N/A
Not yet recruiting	`NCT03839381` - Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments
Recruiting	`NCT06027411` - Assess the Clinical Effectiveness in AI Prioritising CT Heads
Recruiting	`NCT05151978` - Transcranial Doppler in Mild and Moderate Traumatic Brain Injury (TBI)
Recruiting	`NCT04051528` - Do Combinatorial Training Lead to Better Cognition and Daily Participation in TBI Persons With Cognitive Impairments	N/A
Recruiting	`NCT06028906` - Research of Optimal Cerebral Perfusion Pressure Diagnosis
Recruiting	`NCT06083441` - SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury
Recruiting	`NCT03344432` - Correlation Intraocular Pressure With Intracranial Pressure	N/A
Recruiting	`NCT04926987` - The Research of Human Cortex Cell Atlas
Recruiting	`NCT05726201` - (POCUS) As an Early Screening Tool for Diagnosing Skull Fractures in Children
Active, not recruiting	`NCT04564495` - Home Based Tele-exercise for People With Chronic Neurological Impairments	N/A
Active, not recruiting	`NCT04058379` - Artificial Intelligence Analysis of Initial Scan Evolution of Traumatic Brain Injured Patient to Predict Neurological Outcome	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Caregiver Wellness After Traumatic Brain Injury (CG-WELL): An Intervention Designed to Promote Well-being in Caregivers of Acute Moderate to Severe Traumatic Brain Injuries — CG-Well

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms